Effectiveness of highly-active antiretroviral therapy by race/ethnicity-Reference-Cited by-同舟云学术

Effectiveness of highly-active antiretroviral therapy by race/ethnicity

Published:2006-07-13 Issue:11 Volume:20 Page:1531-1538
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Silverberg Michael J,Wegner Scott A,Milazzo Mark J,McKaig Rosemary G,Williams Carolyn F,Agan Brian K,Armstrong Adam W,Gange Stephen J,Hawkes Clifton,O'Connell Robert J,Ahuja Sunil K,Dolan Matthew J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference32 articles.

1. HIV/AIDS among African Americans: progress or progression?;Smith;AIDS,2000

2. Differential survival in blacks and Hispanics with AIDS;Murrain;Ethn Health,1996

3. Association of race and gender with HIV-1 RNA levels and immunologic progression;Anastos;J Acquir Immune Defic Syndr,2000

4. Racial differences in rate of CD4 decline in HIV-1-infected homosexual men;Easterbrook;AIDS,1996

5. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group;Easterbrook;JAMA,1991

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The US Military HIV Natural History Study: Informing Military HIV Care and Policy for Over 30 Years;Military Medicine;2019-11-01

2. Regimen Switching After Initial Haart By Race in a Military Cohort;The Open Public Health Journal;2017-10-28

3. Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC*;AIDS Care;2016-06-13

4. An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial Therapy;PLOS ONE;2016-05-19

5. Non-AIDS-Defining Malignancies in the HIV-Infected Population;Current Infectious Disease Reports;2014-05-21